Angiodynamics (ANGO)

Overall impact
C (60)

Commentary

Angiodynamics is an average overall performer. With a 'C' rating of 59.7 for overall impact (62nd percentile compared to all companies), Angiodynamics ranks 67th out of 103 industry peers, behind Waters, MyMD Pharmaceuticals, Alphatec and 63 others, and ahead of Envista Holdings, LI-COR, Sientra and 33 others. On top material causes for Angiodynamics's industry (Healthcare Equipment), Angiodynamics performs well in Disease Eradication (96.2 score) and performs poorly in Humane Treatment of Animals (18.9 score).
Impact
Cause ANGO
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
632
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Supplies
SASB industry
Medical Equipment & Supplies
Headquarters
Ny, United States
Share classes
ANGO
Description
AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers the Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes the AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and the AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers the NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits that provide interventional physicians a smaller introducer system for minimally invasive procedures; the VenaCure EVLT system that is used in endovascular laser procedures to treat superficial venous disease; and the Solero MTA System, which includes the Solero microwave generator and the specially designed Solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
Material causes
Ethos considers the following causes material for Angiodynamics, based on its industry sub-industry Health Care Supplies. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.